Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The AI In Cancer Diagnostics Market?

The market size for AI in cancer diagnostics has seen an astronomical growth in the past few years. It is anticipated to escalate from a worth of $0.66 billion in 2024 to $0.79 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 21.0%. This substantial growth during the historic period can be linked to factors such as a rise in cancer rates, a surge in healthcare data, conducive regulatory environment, emphasis on precision medicine and the broadening of AI applications beyond just imaging.

It is anticipated that the market size for AI in cancer diagnostics will experience massive growth in the coming years, expanding to $1.65 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 20.0%. This forecasted growth can be linked to the introduction of explainable AI, a global upswing in healthcare IT expenditure, incorporation with electronic health records (EHR), wider acceptance of personalized medicine, and ongoing developments in AI algorithms. Looking ahead, the major trends predicted for this period include advancements in imaging technology, technological amalgamation, partnerships between health and technology corporations, the emergence of digital pathology, and the automation of histopathology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

What Core Drivers Are Expected To Influence The AI In Cancer Diagnostics Market?

The rise in cancer incidences is anticipated to boost the expansion of artificial intelligence in the cancer diagnostics market. Cancer comprises a set of diseases characterized by uncontrolled cell growth with a capability to invade or metastasize to other body regions. The incorporation of AI into cancer care is intended to augment efficiency, precision, and tailor-made treatment choices, eventually enhancing cancer patients’ prognoses. For example, the National Cancer Institute, a US government agency, projected in May 2024 that the U.S. would see about 2 million new cancer diagnoses in 2024, with over 611,000 anticipated deaths. By 2040, new global cancer incidences are predicted to escalate to 29.9 million, with an increase in cancer-related fatalities to 15.3 million. Consequently, the escalating frequency of cancer is fuelling the expansion of artificial intelligence in the cancer diagnostics market.

What Are The Main Segment Classifications In The AI In Cancer Diagnostics Market?

The ai in cancer diagnosticsmarket covered in this report is segmented –

1) By Component: Software Solutions; Hardware; Services

2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types

3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring

4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations

Subsegments:

1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices

3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services

Which Emerging Trends Are Reshaping The AI In Cancer Diagnostics Market Landscape?

Significant advancements in AI-based digital pathology solutions for cancer diagnosis have been a major factor fueling the growth experienced by major companies in the AI in cancer diagnostics market. These AI-powered solutions make use of artificial intelligence algorithms to detect cancer and other diagnostic features across myriad tissue types. This enables precise and timely cancer diagnosis, facilitation for case prioritization and reproducibility of diagnoses. One such advancement was the unveiling of an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe in November 2023, by Dedalus & Ibex Medical Analytics, a Europe-based health software company. The primary aim of this solution is to enhance the accuracy of cancer detection, provision of AI-assisted decision support tools, refining reporting, building laboratory efficiency and augmenting the pace of disease identification.

Which Companies Are Contributing Significantly To The AI In Cancer Diagnostics Market Growth?

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Which Region Holds The Greatest Opportunity For AI In Cancer Diagnostics Market Expansion?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13567&type=smp

Browse Through More Reports Similar to the Global AI In Cancer Diagnostics Market 2025, By The Business Research Company

Ai In Oil And Gas Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-oil-and-gas-global-market-report

Ai Infrastructure Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-infrastructure-global-market-report

Ai In Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model